Regulatory milestone enables single cell sequencing to enter routine clinical diagnostics COLOGNE, GERMANY – Singleron Biotechnologies announced today that its Matrix NEO™ automated single cell processing system has received Class II Medical Device Registration approval from the Jiangsu Medical Products Administration, China (Registration No.: 20252222135). Matrix NEO is the world’s first automated single cell analysis platform to achieve medical […]
Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE — Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (NHCS) to accelerate innovation in metabolic heart failure research, one of the most […]
MARKHAM, Ontario — Alpha Controls & Instrumentation Inc. (“Alpha Controls”), a leading Canadian distributor of instrumentation and provider of calibration, validation and process-control solutions, is pleased to welcome Hamilton to its supplier network, reinforcing the company’s commitment to delivering world-class laboratory equipment, analytical instruments, and bioprocess monitoring solutions to the Canadian market. As Alpha Controls continues to expand […]
MOUNT PLEASANT, SC, UNITED STATES — Efferent Labs, an innovator in real-time biosensor systems that enable continuous biological monitoring, has announced the appointment of Philip D. Manos as Chief Science Officer. The company’s breakthrough technology could dramatically reduce reliance on animal testing and transform how drugs are discovered and diseases are monitored. Manos will lead the scientific […]
CAMBRIDGE, England – biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics (“Watchmaker”) in the United States District Court for the District of Colorado. The lawsuit seeks damages and a court order to stop Watchmaker from making, using, selling, or offering for sale their TAPS+ […]
Patent strengthens 3D Ready™ portfolio, enabling consistent, assay-ready organoids for predictive drug discovery SAN JOSE, Calif. – Molecular Devices, LLC., a leading provider of high-performance life science solutions, today announced the issuance of U.S. Patent No. 12,351,820 B2, titled “Methods for Culturing Organoids.” The patent covers aspects of the company’s novel bioreactor-based method for producing organoids. Molecular Devices’ […]
Kit offers novel protein interactomics analysis of immune cells MORRISVILLE, N.C. and STOCKHOLM — Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced today a partnership to expand access to cutting-edge 3D protein interactomics capabilities to researchers and clinicians in the United States. Carolina Molecular will be the first certified U.S. service provider for […]
NATICK, Mass. — Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a research-use-only (RUO) next-generation sequencing (NGS) kit designed to enable laboratories to perform rapid tumor profiling of lymphoid malignancies. The oncoReveal Lymphoid panel interrogates 84 genes of interest, including full coding DNA sequence (CDS) of 29 genes with a […]
Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. CAMBRIDGE, Mass. and SAN DIEGO, Calif. — Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the two […]
Custom antibody service provides research antibodies that always work—for any target, any species PHILADELPHIA — Cell Surface Bio (CSB) announces the launch VeRSa-Select™, a custom antibody service providing scientists with unparalleled access to the highest quality antibody reagents in the industry for any protein target. These include challenging and structurally complex targets such as GPCRs and ion channels, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
